MIAMI—The Daily Business Review reported on Rivero Mestre’s $126 million-dollar settlement with Blue Cross and Blue Shield of Florida Inc., which has agreed to cover a life-saving treatment for hepatitis C to approximately 2,000 people.
In May 2015, Rivero Mestre filed two class actions against Florida Blue on behalf of people with employer-sponsored plans and non-employer sponsored plans. The lawsuits alleged that Florida Blue was unlawfully rationing a cure by imposing certain coverage requirements on people suffering from hepatitis C, whose livers had not yet developed advanced or severe stages of liver fibrosis. A year later, Rivero Mestre obtained a landmark settlement under which Florida Blue has agreed to remove the contested coverage requirements, paving the way for at least 2,000 people suffering from hepatitis C to now receive a cure to a previously incurable, potentially life-threating disease. The settlement provides at least $126 million dollars’ worth of relief to the settlement class and has far-reaching implications for people suffering from hepatitis C all across the United States.
The suit was also discussed in:
About Rivero Mestre LLP
Rivero Mestre, from its offices in Miami and New York, represents clients from investigation to verdict and appeal in complex business disputes in U.S. federal courts, state courts, and domestic and international arbitration proceedings. The firm’s practice focuses primarily on representing corporate and institutional clients in a broad range of complex commercial disputes including financial institution matters, intellectual property disputes, and litigation and arbitration relating to Latin American trade and investment. For more information, visit www.riveromestre.com.